Top Markets
#1 Akedo Akedo +58.47%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.71%
#4 Cross Cross +45.85%
#5 Black Phoenix Black Phoenix +34.29%
#6 Velvet Velvet +30.75%
#7 OVERTAKE OVERTAKE +19.61%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.83%
#9 Cap Cap +15.18%
#10 QANplatform QANplatform +14.92%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
E-therapeutics Plc E-therapeutics Plc

E-therapeutics Plc

ETX
Rank in Stocks #38863
E-therapeutics Plc, established in 2001 and headquartered in London, UK, is a... E-therapeutics Plc, established in 2001 and headquartered in London, UK, is a drug discovery research company. It employs an advanced computational platform that conducts in silico screening to forecast compounds and biological targets capable of profoundly altering biological systems, drawing insights from its proprietary network models. Additionally, the firm is developing an RNA interference (RNAi) platform aimed at achieving highly specific gene silencing.
Share Price
$0.12246314
Last synced: 2024-05-08
Market Cap
$767.28K
Change (1 day)
1.50%
Change (1 year)
0.00%
Country
GB
Trade E-therapeutics Plc (ETX)

Category

Healthcare
Dividend history for E-therapeutics Plc (ETX)
E-therapeutics Plc (stock symbol: ETX) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for E-therapeutics Plc (ETX) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
29.00%
BE